Effect Of Omega-3 Fatty Acids On Cardiovascular Protection- A Randomised Controlled Clinical Interventional Study

Q3 Pharmacology, Toxicology and Pharmaceutics Journal of Pharmaceutical Negative Results Pub Date : 2023-02-01 DOI:10.47750/pnr.2022.13.s08.592
Rukaiah Fatma Begum, M. Sumithra, R. Velmurugan
{"title":"Effect Of Omega-3 Fatty Acids On Cardiovascular Protection- A Randomised Controlled Clinical Interventional Study","authors":"Rukaiah Fatma Begum, M. Sumithra, R. Velmurugan","doi":"10.47750/pnr.2022.13.s08.592","DOIUrl":null,"url":null,"abstract":"There is a great deal of public belief in the cardiovascular benefits of omega-3 fats. Recent trials of omega-3 fatty acids in cardiovascular issues are unclear or failed to show the significant benefit for reducing cardiovascular events. To perform a human trial of omega 3 fatty acids supplementation to test its effectiveness on cardiovascular diseases. A randomized interventional study was carried out in 145 patients in the age group of 18 or older at any risk of cardiovascular disease. Treatment period of 6 months with supplementation of daily dose of 360 mg of EPA and 480 mg of DHA for one group and to the other group, atorvastatin 10 mg was given. Biochemical and clinical evaluation was performed for the baseline, 3rd and the 6th months to assess the effectiveness of omega 3 fatty acids on cardiovascular diseases. The changes in the biochemical parameters total cholesterol, HDL, LDL and triglycerides among the omega 3 fatty acid group and statin group were as 218.17 vs 204.45, 55.24 vs 60.3, 142.9 vs 132.41and 168.95 vs 152.5 respectively with a p value of 0.0001. Omega 3 supplements have little or no effect on the risk of cardiovascular diseases according to the research. The better evidence identified in this research does not demonstrate any cardiovascular protection with the supplementation of omega 3 fats.","PeriodicalId":16728,"journal":{"name":"Journal of Pharmaceutical Negative Results","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Negative Results","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47750/pnr.2022.13.s08.592","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

There is a great deal of public belief in the cardiovascular benefits of omega-3 fats. Recent trials of omega-3 fatty acids in cardiovascular issues are unclear or failed to show the significant benefit for reducing cardiovascular events. To perform a human trial of omega 3 fatty acids supplementation to test its effectiveness on cardiovascular diseases. A randomized interventional study was carried out in 145 patients in the age group of 18 or older at any risk of cardiovascular disease. Treatment period of 6 months with supplementation of daily dose of 360 mg of EPA and 480 mg of DHA for one group and to the other group, atorvastatin 10 mg was given. Biochemical and clinical evaluation was performed for the baseline, 3rd and the 6th months to assess the effectiveness of omega 3 fatty acids on cardiovascular diseases. The changes in the biochemical parameters total cholesterol, HDL, LDL and triglycerides among the omega 3 fatty acid group and statin group were as 218.17 vs 204.45, 55.24 vs 60.3, 142.9 vs 132.41and 168.95 vs 152.5 respectively with a p value of 0.0001. Omega 3 supplements have little or no effect on the risk of cardiovascular diseases according to the research. The better evidence identified in this research does not demonstrate any cardiovascular protection with the supplementation of omega 3 fats.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Omega-3脂肪酸对心血管保护作用的随机对照临床干预研究
公众对ω-3脂肪对心血管的益处深信不疑。最近关于ω-3脂肪酸治疗心血管疾病的试验尚不清楚或未能显示其对减少心血管事件的显著益处。进行一项补充ω3脂肪酸的人体试验,以测试其对心血管疾病的有效性。对145名年龄在18岁或以上、有心血管疾病风险的患者进行了随机干预研究。治疗期为6个月,其中一组每日补充360 mg EPA和480 mg DHA,另一组每天补充10 mg阿托伐他汀。在基线、第3个月和第6个月进行生化和临床评估,以评估ω-3脂肪酸对心血管疾病的有效性。ω3脂肪酸组和他汀类药物组的总胆固醇、高密度脂蛋白、低密度脂蛋白和甘油三酯的生化参数变化分别为218.17 vs 204.45、55.24 vs 60.3、142.9 vs 132.41和168.95 vs 152.5,p值为0.0001。研究表明,欧米茄3补充剂对心血管疾病的风险几乎没有影响。这项研究中发现的更好的证据并没有证明补充ω3脂肪对心血管有任何保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Chinese Spinach (Amaranthus viridis Linn.) as Natural Molluscicide Against the Hatchability of Golden Apple Snail (Pomacea canaliculata Lamarck) Eggs Molluscicidal Activity Of Cashew (Anarcadium Occidentale Linn.) Apple Against Golden Apple Snail (Pomacea Canaliculata Lamarck) Effectiveness Of Simulation- Based Learning In Term Of Competency Regarding Pre-Term Newborn Care Among Nursing Students: An Quasi Experimental Study Synthesis, Characterization, Antibacterial Activity And Molecular Docking Studies Of Novel Nitrogen Based Indole-2-One Schiff’s Bases Emergency Obstetric Complications During Labour And Delivery Among Mothers Attending Maternity Teaching Hospital /Erbil City/ Iraq. A Cross-Sectional Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1